The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Large Will The Oligonucleotide Synthesis Market Be By 2030 Compared To Its 2026 Market Size?
The oligonucleotide synthesis market size has experienced rapid growth in recent years. It is projected to increase from $11.92 billion in 2025 to $13.9 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.6%. This historical growth can be attributed to several factors, including the high cost of synthesis equipment, limited availability of custom oligos, a dependency on manual synthesis processes, low awareness among researchers, and lengthy production timelines.
The oligonucleotide synthesis market is anticipated to undergo significant growth in the near future. This market is predicted to reach $26.08 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.1%. This projected expansion is attributable to several factors, including an escalating need from therapeutic and diagnostic uses, wider implementation of automated synthesis platforms, progress in gene therapy studies, increased capital allocation for biotechnology research, and the worldwide proliferation of oligo-based research and diagnostic methods. Key developments anticipated during this timeframe encompass breakthroughs in gene editing and individualized medicine, the incorporation of cloud-based data management systems, the utilization of artificial intelligence for optimizing sequence design, enhanced automation within oligonucleotide synthesis procedures, and IoT-driven monitoring of equipment and process tracking.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12176&type=smp
Which Key Factors Are Driving The Oligonucleotide Synthesis Market Growth?
The increasing occurrence of chronic diseases is anticipated to drive the future expansion of the oligonucleotide synthesis market. These are defined as conditions persisting for a year or more, necessitating ongoing medical care and potentially deteriorating over time. Oligonucleotides influence gene expression linked to chronic diseases through diverse mechanisms, acting on mRNA, pre-mRNA, or non-coding RNA to adjust splicing, prompt degradation, or disrupt protein translation. For example, the World Health Organization, a Switzerland-based intergovernmental body, reported in February 2024 that more than 35 million new cancer cases are forecast by 2050, showing a 77% rise from the approximately 20 million cases estimated in 2022. Consequently, the growing incidence of chronic and rare diseases is a key factor propelling the oligonucleotide synthesis market’s expansion.
What Segment Categories Shape The Oligonucleotide Synthesis Market Segment Landscape?
The oligonucleotide synthesis market covered in this report is segmented –
1) By Type: Custom Oligos, Predesigned Oligos
2) By Solution Type: Oligonucleotides, Reagents, Equipment, Services, Purification, Modification
3) By Application: Therapeutic Applications, Research Applications, Diagnostic Applications
Subsegments:
1) By Custom Oligos: Long Oligonucleotides, Short Oligonucleotides, Modified Oligonucleotides
2) By Predesigned Oligos: Gene-Specific Oligos, Probe Oligos, Primers For PCR And RT-PCR
Which Trends Are Guiding The Direction Of The Oligonucleotide Synthesis Market?
Leading firms within the oligonucleotide synthesis market are concentrating on creating novel DNA products aimed at improving sequence precision, streamlining operational processes, and facilitating sophisticated research endeavors. As an illustration, during July 2024, Ansa Biotechnologies, Inc., a company from the US focused on manufacturing complex DNA, introduced its Ansa Clonal DNA and Ansa DNA Fragments. Ansa Clonal DNA delivers clonal, entirely sequence-accurate DNA, extending up to 600 base pairs, thereby removing the requirement for assembly and providing unparalleled accuracy for intricate synthetic biology projects. This particular product guarantees DNA sequences that are free of errors and ready for immediate use, establishing it as a dependable option for researchers. Furthermore, Ansa DNA Fragments presents sequence-verified linear double-stranded DNA fragments, also measuring up to 600 base pairs, specifically designed for a variety of research purposes. Leveraging its inventive enzymatic synthesis method, Ansa consistently manufactures elaborate DNA constructs, encompassing repeats and secondary structures, with significant exactitude.
Who Are The Companies Operating Across The Oligonucleotide Synthesis Market Value Chain?
Major companies operating in the oligonucleotide synthesis market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Nitto Denko Avecia Inc., Alnylam Pharmaceuticals Inc., Maravai Life Sciences, LGC Limited, Ionis Pharmaceuticals Inc., GenScript Inc., Ajinomoto Bio-Pharma Services, Sarepta Therapeutics Inc., Integrated DNA Technologies Inc., Twist Bioscience Corporation, Eurogentec SA, Kaneka Eurogentec S.A., Biocomma Limited, Bio-Synthesis Inc., TriLink BioTechnologies Incorporated, Generi Biotech s.r.o., ATDBio Ltd., BioAutomation Corporation, Biolegio B.V., Dharmacon Research Inc.
Get The Full Oligonucleotide Synthesis Market Report:
https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report
Which Region Holds The Highest Market Share In The Oligonucleotide Synthesis Market?
North America was the largest region in the oligonucleotide synthesis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oligonucleotide synthesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Oligonucleotide Synthesis Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report
Browse Through More Reports Similar to the Global Oligonucleotide Synthesis Market 2026, By The Business Research Company
Sterilization Services Market Report 2026
https://www.thebusinessresearchcompany.com/report/sterilization-services-global-market-report
Terminal Sterilization Services Market Report
Sterilization Equipment Market Report
https://www.thebusinessresearchcompany.com/report/sterilization-equipment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model